newsfilter
← Latest News
Business Wire·

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Pulse Biosciences granted equity inducement awards to four new employees on November 19, 2026, under its 2017 Inducement Equity Incentive Plan.
  • The Compensation Committee approved the awards in compliance with Nasdaq Listing Rule 5635(c)(4).
  • The awards consist of options to purchase up to 6,300 shares of common stock in aggregate.
  • The exercise price for the options is set at $44.41 per share, matching the closing stock price on the grant date.
  • All options are subject to time-based vesting over four years, with 1/4 vesting annually contingent on continued employment.
Keywords
Health,Health Technology,Medical Devices